Critical Analysis of White House Anti-Drug Plan
Glob J Addict Rehabil Med
.
2017 Apr;1(4):555568.
doi: 10.19080/gjarm.2017.01.555568.
Epub 2017 Apr 27.
Authors
Kenneth Blum
1
2
3
4
5
6
7
8
9
10
,
Lyle Fried
7
,
Margaret A Madigan
4
,
John Giordano
10
,
Edward J Modestino
11
,
Bruce Steinberg
11
,
David Baron
2
,
Michael DeLeon
12
,
Thomas McLaughlin
13
,
Mary Hauser
3
,
Rajendra D Badgaiyan
9
Affiliations
1
Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, USA.
2
Department of Psychiatry and Behavioral Sciences, Keck Medicine University of Southern California, USA.
3
Division of Applied Clinical Research & Education, Dominion Diagnostics, LLC, USA.
4
Geneus Health LLC, USA.
5
Division of Reward Deficiency Syndrome and Addiction Therapy, Nupathways, Inc., USA.
6
Department of Clinical Neurology, Path Foundation NY, USA.
7
Division of Neuroscience-Based Addiction Therapy, The Shores Treatment & Recovery Center, USA.
8
Eötvös Loránd University, Institute of Psychology, Europe.
9
Department of Psychiatry, Wright State University Boonshoft School of Medicine and Dayton VA Medical Center, USA.
10
National Foundation For Holistic Addiction Studies, USA.
11
Department of Psychology, Curry College, USA.
12
Steer Straight Inc., Vinland, NJ USA and Banyan Treatment Center, USA.
13
Center For Psychiatric Medicine, USA.
PMID:
29057394
PMCID:
PMC5649359
DOI:
10.19080/gjarm.2017.01.555568
No abstract available
Grants and funding
R01 NS073884/NS/NINDS NIH HHS/United States
R21 MH073624/MH/NIMH NIH HHS/United States